Telix Pharmaceuticals Ltd. (TLX)
7.10
+0.14
(+2.01%)
USD |
NASDAQ |
Feb 06, 16:00
7.10
0.00 (0.00%)
After-Hours: 20:00
Telix Pharmaceuticals Market Cap : 2.377B for Feb. 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Inspire Medical Systems, Inc. | 1.909B |
| Immutep Ltd. | 381.36M |
| Alterity Therapeutics Ltd. | 63.98M |
| Kazia Therapeutics Ltd. | 65.64M |
| Algorae Pharmaceuticals Ltd. | 13.33M |
Market Cap Related Metrics
| PS Ratio | 3.680 |
| Price to Book Value | 20.11 |
| Price | 7.10 |
| Earnings Yield | 0.44% |
| Operating PE Ratio | 80.88 |
| Normalized PE Ratio | 130.51 |